Medtronic, Inc. (MDT) PT Raised to $120 at Needham & Company Following Mazor Deal
Tweet Send to a Friend
Needham & Company analyst Mike Matson raised the price target on Medtronic, Inc. (NYSE: MDT) to $120.00 (from $119.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
